NYS OASAS Credit Approved! See Other Credit Options
This activity is designed to change: Competence, Performance, Patient Outcome. 4 hr(s)
Overview
Educational Objectives:
After completing this activity participants will be able to:
- Select and utilize tobacco, alcohol, and drug use screening tools with patients.
- Perform brief interventions for tobacco and substance use problems with patients.
- To utilize basic motivational interviewing techniques to motivate people having substance use problems to change behaviors in order to improve health.
- Refer patients to the appropriate type of substance abuse treatment center and/or specialist
- Follow-up with and reassess patients who receive treatment for substance abuse or tobacco use
- Apply the SBIRT approach to substance use problems at a comprehensive and integrated level by individualizing screening, brief interventions, and referral for different patients.
Modules in this Training Activity
Activity Content
Audience and Accreditation
Audience: Primary care providers and counselors
| Type | Est. Time | Released | Expires |
|---|---|---|---|
| NBCC | 4 hr(s) | 3/1/23 | 2/28/24 |
| NYS OASAS | 4 hr(s) | 3/31/20 | 4/1/23 |
| DCBN | 4 hr(s) | 4/5/21 | 4/4/23 |
| FBM | 4 hr(s) | 4/5/21 | 4/4/23 |
| FAPA | 4 hr(s) | 4/5/21 | 4/4/23 |
| AMA PRA Category 1 Credit(s)™ | 4hr(s) | 4/5/21 | 4/4/24 |
| FBN | 4 hr(s) | 4/5/21 | 4/4/23 |
Accreditation Statement: Clinical Tools, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
State Medical Board of Ohio Accreditation Statement: Clinical Tools, Inc. is recognized by the State Medical Board of Ohio as an accredited provider of continuing medical education for physicians.
NYS OASAS Credit Statement: Clinical Tools, Inc. designates this enduring material for a maximum of 4 hour(s) of NYS OASAS credit. Providers and other health professionals should claim only the credit commensurate with the extent of their participation in the activity.
DCBN Credit Statement: Clinical Tools, Inc. designates this enduring material for a maximum of 4 hour(s) of DCBN credit. Clinical Tools, Inc. is an approved provider by the District of Columbia Board of Nursing and is registered with CE Broker, Provider #50-1942.
FBM Credit Statement: Clinical Tools, Inc. designates this enduring material for a maximum of 4 hour(s) of FBM credit. Providers and other health professionals should claim only the credit commensurate with the extent of their participation in the activity.
FBN Credit Statement: Clinical Tools, Inc. designates this enduring material for a maximum of 4 hour(s) of FBN credit. Providers and other health professionals should claim only the credit commensurate with the extent of their participation in the activity.
FAPA Credit Statement: Clinical Tools, Inc. designates this enduring material for a maximum of 4 hour(s) of FAPA credit. Providers and other health professionals should claim only the credit commensurate with the extent of their participation in the activity.
Arkansas State Board of Nursing Accreditation Statement: Clinical Tools, Inc. is recognized by the Arkansas State Board of Nursing as an accredited provider of continuing medical education for nurses.
AMA PRA Category 1 Credit™ Designation Statement: Clinical Tools, Inc. designates this enduring material for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NBCC Credit Statement: Clinical Tools, Inc. designates this enduring material for a maximum of 4 clock hour(s) of NBCC credit. Clinical Tools, Inc. has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6161. Activities that do not qualify for NBCC credit are clearly identified. Clinical Tools is solely responsible for all aspects of the activity.
A letter of completion for 4 hours is available for non-physicians.
A score of 70% on the post-test is required to complete the activity.
Funding
Initial development of this activity was supported by a contract from the National Institute on Drug Abuse (#HHSN271200800038C).
